The correlation between serum asprosin and type 2 diabetic patients with obesity in the community
AimsAsprosin is a newly discovered adipokine, it is associated with the insulin resistance, lipid metabolism disorder, diabetes and obesity. However, there have been no reports on the relationship between asprosin and type 2 diabetic patients with obesity. This study aims to investigate the relation...
Saved in:
| Main Authors: | Dong Liang, Xiaoyu Li, Chenyu Xiang, Minggang Xu, Yi Ren, Fen Zheng, Lijing Ma, Jing Yang, Yan Wang, Linxin Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1535668/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations
by: Lijing Ma, et al.
Published: (2024-12-01) -
Asprosin and Neuregulin 4 in Obesity in Children
by: Ramazan Dulkadir, et al.
Published: (2025-04-01) -
Asprosin Levels in Adults with Type 2 Diabetes Mellitus and Diabetic Kidney Disease: A Systematic Review and Meta-Analysis
by: Ristic J, et al.
Published: (2025-07-01) -
Relationship of asprosin and diabetes: a meta-analysis
by: Xiandong Zeng, et al.
Published: (2025-01-01) -
Low Serum Asprosin Levels in Fibromyalgia Syndrome: Insights from a Cross-Sectional Study
by: Muhammed Fuad Uslu, et al.
Published: (2025-02-01)